Certain factors were associated with heart palpitations in menopause, according to findings of a scoping literature review in Women’s Health.
“We wanted to understand what research had been done and what research is still needed to help women with menopause palpitations,” Janet S. Carpenter, PhD, RN, FAAN, a distinguished professor and the Audrey Geisel Endowed Chair in Innovation at the Indiana University School of Nursing, told Healio. Read more in Healio.
Women with a history of premature menopause, defined as menopause before age 40 years, are more likely to develop HF or atrial fibrillation over 9 years of follow-up compared with women without premature menopause, data show.
In a Korean database analysis of more than 1.4 million women, researchers also found that premature menopause was significantly associated with CHD compared with all other categories of age at menopause. Read more in Healio.
Despite an increased incidence and prevalence of rheumatic heart disease worldwide from 1990 to 2019, death and disability caused by the condition trended downward, according to data published in Arthritis Research &Therapy.
“Due to the high risks of premature morbidity, mortality and disability, [rheumatic heart disease (RHD)] remains a critical public health issue worldwide, particularly in many low-income countries,” Zejin Ou, PhD, of Guangzhou Twelfth People’s Hospital, in Guangzhou, China, and co-authors wrote. Read more in Healio.
In women with a high-sodium diet, every 1 g increase in daily potassium intake was associated with a 2.4 mm Hg lower systolic BP, according to data from a large cohort study.
In an analysis of long-term cohort data, researchers also found that women within the highest tertile of potassium intake had an 11% lower risk for incident and/or recurrent CVD events during nearly 20 years of follow-up compared with women with the lowest tertile of potassium intake, with a smaller but still significant CVD benefit observed for men.
Read more in Healio.
Sleep inducer prescriptions were unrelated to increased risk for mortality, major adverse CV events and HF events in patients at a CV hospital, researchers reported in theEuropean Journal of Preventive Cardiology.
“Cardiovascular diseases or concomitant cardiovascular risks are major reasons for prescribing pharmacological sleep inducers as they may trigger insomnia through anxiety or polypharmacy,” Emi Fujii, MD, of the department of cardiovascular medicine at the Cardiovascular Institute in Tokyo, and colleagues wrote. “This study investigated the association between sleep inducer prescriptions and the prognosis of patients visiting a cardiovascular hospital.” Read more in Healio.
The risk of arrhythmias and sudden cardiac death significantly affected medium and long-term outcomes in heart transplant (HT) recipients, who were a special and susceptible population. Data from the National Inpatient Sample from 2009 to 2018 were examined retrospectively. Patients who underwent HT or who have had HT and received newly implanted cardioverter-defibrillators (ICDs) were included in the hospitalization data (excluding the preexisting ICD). Read more in Physician’s Weekly.
The families of five children waiting for heart transplants at one hospital are urging people to consider becoming organ donors.
Ten-month-old Leyla Bell, 18-month-old Beatrix Adamson-Archbold, Luke Myles, one, Ethan Mains, three, and Nour Hussein, eight, are being cared for at Newcastle’s Freeman Hospital. Read the full story from BBC News.
People infected with COVID-19 do not have increased long-term risks for developing cardiovascular disease or diabetes, according to a study published in PLOS Medicine.
In findings from a population-based cohort study conducted in the U.K., the increased risk for CVD in people who contract COVID-19 begins to decline 5 weeks after infection, whereas the risk for diabetes remains elevated up to 23 weeks after infection before dropping back to preinfection levels. Read more in Healio.
In the past month, researchers transplanted pig hearts into two people who had suffered catastrophic heart failure and were left brain dead but remained on life support.
New research in which doctors transplanted genetically modified pig hearts into people who were clinically dead could pave the way for human trials and a future with more organ transplants that can prolong lives.
In the past month, researchers at NYU Langone Health transplanted pig hearts into two people who had recently suffered catastrophic heart failure and were left brain dead but remained on life support. Read more from NBC News here.
The U.S. has had the same leading cause of death since 1921. Today, one person in America dies every 34 seconds from this disease. This disease doesn’t care about your demographics — men, women, and most racial and ethnic groups are all affected. The disease in question is none other than heart disease.
We’re surrounded by daily advertisements for methods of combating heart disease. Additionally, the U.S. spends around $229 billion annually in heart-disease related healthcare services, medicine, and lost productivity due to death. The good news? This disease is largely preventable. Read the full story in MedPage Today.